Effect of Levonorgestrel-Releasing Intrauterine System in the Treatment of Adenomyosis
article
OA: closed
CC0
⤵ 2 in-corpus citations
AI-generated summary
Levonorgestrel-releasing intrauterine system treatment of adenomyosis significantly reduced dysmenorrhea and led to oligomenorrhea or amenorrhea in most patients within one year.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Objective:To evaluate the clinical effect of levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of adenomyosis.Methods:One hundred-two patients with adenomyosis were treated with LNG-IUS,and the menstrual patterns,severity of dysmenorrhea and side effects were observed at baseline and 1,3,6,12 months after treating with LNG-IUS.Results:①102 cases were followed after device insertion,8 cases requested removal of the device(5 for oligomenorrhea,and 3 for acne).At 12 months,the overall continuation rate was 92.16%(94/102);②The VAS and VRS of dysmenorrhea dropped continuously and significantly after the LNG-IUS insertion (P0.05);③Oligomenorrhea occurred in 68.63%,78.43% and 91.49% patients at 1,3,12 months after insertion,respectively.④Irregular bleeding was the main side effect,which occurred in 19 women 1 month after insertion and in 12 women 3 months after insertion.After 6 months of observation,irregular bleeding was not present in any patient.In addition,6 women reported amenorrhea in 12 months after insertion.Conclusions:LNG-IUS is an effective method for controlling the symptoms of adenomyosis in one year's observation.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (2)
- Long-term Efficacy and Safety of Levonorgestrel - releasing Intrauterine System in the Treatment of Adenomyosis: Evidence Mapping and Meta-analysis 2022
- Efeitos do sistema intra-uterino de Levonorgestrel sobre marcadores de risco cardiovascular de pacientes com endometriose: estudo comparativo com o análogo do GnRH 2009
Cited by (2)
- Long-term Efficacy and Safety of Levonorgestrel - releasing Intrauterine System in the Treatment of Adenomyosis: Evidence Mapping and Meta-analysis 2022
- Efeitos do sistema intra-uterino de Levonorgestrel sobre marcadores de risco cardiovascular de pacientes com endometriose: estudo comparativo com o análogo do GnRH 2009
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK